<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01303757</url>
  </required_header>
  <id_info>
    <org_study_id>10-04-0156</org_study_id>
    <nct_id>NCT01303757</nct_id>
  </id_info>
  <brief_title>A Novel Diet-Phenotype Interaction Affecting Body Weight</brief_title>
  <acronym>FRESH Start</acronym>
  <official_title>A Novel Diet-Phenotype Interaction Affecting Body Weight</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Broad Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of the study is to examine insulin secretion as an effect modifier of the&#xD;
      efficacy of a low-fat vs. low-glycemic load diet for weight loss among overweight/obese young&#xD;
      adults in an 18-month, prospectively stratified, multi-center randomized controlled trial.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In recent years, diets of widely varying composition have been used in the treatment of&#xD;
      obesity. While none of these diets has produced consistent, long-term weight loss, some&#xD;
      individuals on virtually all types of diets do remarkably well. One explanation for this&#xD;
      variation among individuals is differences in motivation and behavior. However, underlying&#xD;
      biological differences may also play an important role. Previous work has identified insulin&#xD;
      secretion (as quantified by serum insulin concentration at 30 minutes following a standard&#xD;
      75-gram oral glucose load) as an important biological determinant. This&#xD;
      randomized-controlled, multi-center trial aims to test the hypothesis that insulin secretion&#xD;
      will predict which type of diet will work best for each individual. A total of 160 obese&#xD;
      young adults (18 to 40 years) will be assigned to one of two diets: low-fat (60%&#xD;
      carbohydrate, 20% fat, 20% protein) or low-glycemic load (45% carbohydrate, 35% fat, 20%&#xD;
      protein). Participants will be enrolled at two sites (Children's Hospital Boston or&#xD;
      University of North Carolina-Chapel Hill) and assigned to diet groups according to baseline&#xD;
      insulin secretion status. The protocol will include an intensive 6-month intervention period&#xD;
      and a 12-month follow-up period. Registered dietitians will provide nutrition education and&#xD;
      behavioral counseling during group workshops and scheduled telephone calls. In an effort to&#xD;
      avoid confounding, close attention will be paid to control for treatment intensity, physical&#xD;
      activity prescriptions, and behavioral methods between groups. The primary endpoint will be&#xD;
      percent body fat by DXA scan. Secondary endpoints will include cardiovascular and diabetes&#xD;
      risk factors. Repeated, 24-hour dietary and physical activity recall interviews will provide&#xD;
      process data. Metabolomic profiling and molecular analysis of identified metabolites will be&#xD;
      conducted to characterize phenotype and explore potential physiological mechanisms. A&#xD;
      successful outcome of this work will inform the practice of &quot;personalized&quot; nutritional&#xD;
      therapy, enhancing the ability to select the most efficacious weight loss diet for an&#xD;
      individual based on underlying biological differences.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent body fat by dual-energy x-ray absorptiometry (DXA)</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Triglyceride</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL cholesterol</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL cholesterol</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasminogen Activator Inhibitor-1</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting blood glucose</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trunk fat</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Serum insulin concentration 30 minutes following a standard 75-gram oral glucose load</measure>
    <time_frame>18 months</time_frame>
    <description>Effect modification</description>
  </other_outcome>
  <other_outcome>
    <measure>Metabolomic profile</measure>
    <time_frame>18 months</time_frame>
    <description>Effect modification</description>
  </other_outcome>
  <other_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>18 months</time_frame>
    <description>Effect modification</description>
  </other_outcome>
  <other_outcome>
    <measure>Abdominal-to-total fat ratio</measure>
    <time_frame>18 months</time_frame>
    <description>Effect modification</description>
  </other_outcome>
  <other_outcome>
    <measure>Waist-to-hip ratio</measure>
    <time_frame>18 months</time_frame>
    <description>Effect modification</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">155</enrollment>
  <condition>Obesity</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Low glycemic load diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low glycemic load diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low fat diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low fat diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dietary counselling</intervention_name>
    <arm_group_label>Low fat diet</arm_group_label>
    <arm_group_label>Low glycemic load diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Aged 18 to 40 years.&#xD;
&#xD;
          -  Body mass index (BMI) ≥ 27 kg/m2.&#xD;
&#xD;
          -  Body weight ≤ 300 lb.&#xD;
&#xD;
          -  Access to a working telephone.&#xD;
&#xD;
          -  Clearance in writing from a primary care provider (i.e., physician or nurse&#xD;
             practitioner) to rule out pre-existing medical conditions.&#xD;
&#xD;
          -  Willing and able to attend group workshops (for dietary intervention) on specified&#xD;
             evenings.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Physician diagnosis of a major medical illness or eating disorder.&#xD;
&#xD;
          -  Chronic use of any medication that may affect study outcomes (e.g.,&#xD;
             insulin-sensitizing agents).&#xD;
&#xD;
          -  Current smoking (i.e., 1 cigarette in the past week).&#xD;
&#xD;
          -  Physical, mental, or cognitive handicaps that prevent participation.&#xD;
&#xD;
          -  Another member of the family (i.e., first degree relative) or household participating&#xD;
             in the study.&#xD;
&#xD;
          -  Planning to relocate from current area of residence during the proposed timeframe for&#xD;
             study participation.&#xD;
&#xD;
          -  If female, planning to become pregnant during the 18 months of the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cara B Ebbeling, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Boston Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David S Ludwig, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Leslie Fischer, PhD</last_name>
    <role>Study Director</role>
    <affiliation>UNC Chapel Hill</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina, Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <study_first_submitted>February 22, 2011</study_first_submitted>
  <study_first_submitted_qc>February 23, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 25, 2011</study_first_posted>
  <last_update_submitted>February 8, 2016</last_update_submitted>
  <last_update_submitted_qc>February 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children's Hospital</investigator_affiliation>
    <investigator_full_name>David S. Ludwig, MD, PhD</investigator_full_name>
    <investigator_title>Director, Obesity Prevention Center</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Body Weight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

